BridgeBio Oncology Therapeutics (BBOT) Share-based Compensation (2024 - 2026)
BridgeBio Oncology Therapeutics' Share-based Compensation came in at $7.23 million for Q2 2026, compared with $36,000 a year earlier and up 86.7% from the prior quarter.
Powered by 
Analysis
BridgeBio Oncology Therapeutics (BBOT) Share-based Compensation (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BridgeBio Oncology Therapeutics reported Share-based Compensation of $15.47 million; for FY2025, it was $5.87 million, up 32.7% from FY2024.
- Going back by year, Share-based Compensation was $4.43 million in FY2024.
- The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q1 2024.
- Business Quant data shows BBOT's Share-based Compensation at $3.87 million (Q1 2026), $2.95 million (Q4 2025) and $1.43 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | BridgeBio Oncology Therapeutics | 213.74 Mn | -1.16 Bn | - | 7.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.23 Mn |
| Mar 31, 2026 | 3.87 Mn |
| Dec 31, 2025 | 2.95 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 875,000.00 |
| Mar 31, 2025 | 627,000.00 |
| Dec 31, 2024 | 587,000.00 |
| Sep 30, 2024 | 768,000.00 |
| Jun 30, 2024 | 279,000.00 |
| Mar 31, 2024 | 660,000.00 |
API Access
BridgeBio Oncology Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BBOT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "BBOT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BBOT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();